查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1969882

全球原位雜合反應市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global In Situ Hybridization Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

原位雜合反應市場預計將從 2025 年的 23.4 億美元成長到 2034 年的 45.6 億美元，2026 年至 2034 年的複合年成長率為 7.71%。

受先進分子診斷技術需求不斷成長的推動，全球原位雜合反應市場正經歷穩定成長。原位雜合反應（ISH）廣泛用於檢測組織和細胞內的特定DNA或RNA序列。癌症和遺傳疾病的日益普遍增加了對精準診斷工具的需求，從而推動了實驗室和臨床檢查室對ISH技術的需求。

生物技術的進步和基因組研究投入的增加是推動該成長要素。個人化醫療和標靶治療的引入也促進了ISH技術的廣泛應用。醫院和診斷檢查室擴大採用先進的分子檢測技術，以提高疾病檢測的準確性和治療方案的發展。政府對生命科學研究的支持也進一步推動了市場發展。

未來，自動化原位雜合技術系統和改進的探針設計等技術創新有望推動市場發展。開發中國家醫療基礎設施的擴建將創造新的成長機會。隨著癌症生物學和遺傳疾病研究的不斷深入，對原位雜合反應等精準可靠的診斷解決方案的需求預計將穩定成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球原位雜合反應市場：依技術分類

  • 市場分析、洞察與預測
  • FISH
  • CISH

第5章 全球原位雜合反應市場：依探針類型分類

  • 市場分析、洞察與預測
  • DNA
  • RNA

第6章 全球原位雜合反應市場：依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 耗材和配件
  • 軟體
  • 服務

第7章 全球原位雜合反應市場：依應用分類

  • 市場分析、洞察與預測
  • 癌症
  • 細胞遺傳學
  • 發育生物學
  • 感染疾病
  • 其他

第8章 全球原位雜合反應市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院/診斷檢查室
  • CRO
  • 學術研究機構
  • 其他

第9章 全球原位雜合反應市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher Scientific Inc
    • Abbott
    • PerkinElmer Inc
    • BioView
    • Agilent Technologies Inc
    • Merck KGaA
    • Bio-Rad Laboratories Inc
    • Advanced Cell Diagnostics
    • LGC Biosearch Technologies
    • Bio-Techne
    • Abcam
簡介目錄
Product Code: VMR112110579

The In Situ Hybridization Market size is expected to reach USD 4.56 Billion in 2034 from USD 2.34 Billion (2025) growing at a CAGR of 7.71% during 2026-2034.

The Global In Situ Hybridization Market is experiencing consistent growth due to increasing demand for advanced molecular diagnostic techniques. In situ hybridization (ISH) is widely used for detecting specific DNA or RNA sequences in tissues and cells. The growing prevalence of cancer and genetic disorders has increased the need for accurate diagnostic tools, which is driving the demand for ISH technologies in research and clinical laboratories.

Key growth drivers include advancements in biotechnology and rising investments in genomics research. The adoption of personalized medicine and targeted therapies is also boosting the use of ISH techniques. Hospitals and diagnostic laboratories are increasingly integrating advanced molecular testing methods to improve disease detection and treatment planning. Government support for life sciences research further strengthens market development.

In the future, the market is expected to benefit from technological innovations such as automated ISH systems and improved probe design. Expanding healthcare infrastructure in developing countries will create new growth opportunities. As research in cancer biology and genetic diseases continues to advance, the demand for precise and reliable diagnostic solutions like in situ hybridization will continue to rise steadily.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Fish
  • Cish

By Probe Type

  • DNA
  • RNA

By Product

  • Instruments
  • Consumables & Accessories
  • Software
  • Services

By Application

  • Cancer
  • Cytogenetics
  • Developmental Biology
  • Infectious Diseases
  • Others

By End-use

  • Hospitals & Diagnostic Laboratories
  • CROs
  • Academic & Research Institutes
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific Inc, Abbott, PerkinElmer Inc, BioView, Agilent Technologies Inc, Merck KGaA, BioRad Laboratories Inc, Advanced Cell Diagnostics, LGC Biosearch Technologies, BioTechne, Abcam
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL IN SITU HYBRIDIZATION MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Fish Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Cish Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL IN SITU HYBRIDIZATION MARKET: BY PROBE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Probe Type
  • 5.2. DNA Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. RNA Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL IN SITU HYBRIDIZATION MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Product
  • 6.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Consumables & Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL IN SITU HYBRIDIZATION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Application
  • 7.2. Cancer Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Cytogenetics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Developmental Biology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL IN SITU HYBRIDIZATION MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Hospitals & Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. CROs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL IN SITU HYBRIDIZATION MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Technology
    • 9.2.2 By Probe Type
    • 9.2.3 By Product
    • 9.2.4 By Application
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Technology
    • 9.3.2 By Probe Type
    • 9.3.3 By Product
    • 9.3.4 By Application
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Technology
    • 9.4.2 By Probe Type
    • 9.4.3 By Product
    • 9.4.4 By Application
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Technology
    • 9.5.2 By Probe Type
    • 9.5.3 By Product
    • 9.5.4 By Application
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Technology
    • 9.6.2 By Probe Type
    • 9.6.3 By Product
    • 9.6.4 By Application
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL IN SITU HYBRIDIZATION INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Thermo Fisher Scientific Inc
    • 11.2.2 Abbott
    • 11.2.3 PerkinElmer Inc
    • 11.2.4 BioView
    • 11.2.5 Agilent Technologies Inc
    • 11.2.6 Merck KGaA
    • 11.2.7 Bio-Rad Laboratories Inc
    • 11.2.8 Advanced Cell Diagnostics
    • 11.2.9 LGC Biosearch Technologies
    • 11.2.10 Bio-Techne
    • 11.2.11 Abcam